HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Tanja N Fehm Selected Research
Tanja N Fehm Research Topics
Disease
37
Breast Neoplasms (Breast Cancer)
03/2022 - 12/2011
11
Neoplasms (Cancer)
03/2022 - 06/2012
6
Triple Negative Breast Neoplasms
05/2021 - 06/2012
4
Endometriosis
03/2022 - 06/2017
4
Neoplasm Metastasis (Metastasis)
12/2020 - 12/2011
2
Circulating Neoplastic Cells
01/2022 - 01/2017
2
Ovarian Neoplasms (Ovarian Cancer)
12/2019 - 03/2018
1
Infertility (Sterility)
03/2022
1
Leukopenia
01/2022
1
Pathologic Complete Response
05/2021
1
Metrorrhagia (Spotting)
01/2021
1
Endometritis
12/2020
1
Brain Neoplasms (Brain Tumor)
12/2018
1
Nausea
03/2018
1
Vomiting
03/2018
1
Alopecia (Baldness)
03/2018
1
Spontaneous Abortion (Miscarriage)
06/2017
1
Cardiotoxicity
01/2017
Drug/Important Bio-Agent (IBA)
11
Hormones (Hormone)
IBA
05/2021 - 06/2012
5
Biomarkers (Surrogate Marker)
IBA
03/2022 - 03/2018
5
Poly(ADP-ribose) Polymerase Inhibitors
IBA
02/2022 - 03/2018
5
pertuzumab
IBA
06/2021 - 01/2019
3
Progesterone Receptors (Progesterone Receptor)
IBA
03/2022 - 04/2020
3
Immune Checkpoint Inhibitors
IBA
05/2021 - 04/2020
2
Estrogen Receptors
IBA
03/2022 - 01/2017
2
Ligands
IBA
03/2022 - 06/2012
2
Phenobarbital (Luminal)
FDA Link
01/2022 - 04/2021
2
Pharmaceutical Preparations
IBA
02/2021 - 12/2020
2
Anthracyclines
IBA
10/2020 - 01/2017
2
Ado-Trastuzumab Emtansine
IBA
10/2020 - 10/2019
1
CXC Chemokines
IBA
03/2022
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2022
1
Syndecan-1 (Syndecan 1)
IBA
03/2022
1
talazoparib
IBA
02/2022
1
giredestrant
IBA
02/2022
1
Circulating Tumor DNA
IBA
01/2022
1
Complement System Proteins (Complement)
IBA
01/2022
1
neratinib
IBA
06/2021
1
Capecitabine (Xeloda)
FDA Link
06/2021
1
Cyclin-Dependent Kinase 4
IBA
05/2021
1
Immunoconjugates (Immunoconjugate)
IBA
05/2021
1
Thyrotropin (Thyroid-Stimulating Hormone)
FDA Link
01/2021
1
DNA (Deoxyribonucleic Acid)
IBA
01/2021
1
Doxycycline (Periostat)
FDA Link
Generic
12/2020
1
seribantumab
IBA
11/2020
1
histidine-rich proteins
IBA
11/2020
1
Gemcitabine
FDA Link
10/2020
1
Taxoids (Taxanes)
IBA
10/2020
1
atezolizumab
IBA
12/2019
1
Biological Products
IBA
10/2019
1
Trastuzumab (Herceptin)
FDA Link
01/2019
1
human ERBB2 protein
IBA
12/2018
1
Testosterone (Sustanon)
FDA Link
06/2017
1
Estrogens (Estrogen)
FDA Link
01/2017
1
G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
IBA
01/2017
1
Ceramides
IBA
06/2012
1
Proteins (Proteins, Gene)
FDA Link
06/2012
1
ErbB Receptors (EGF Receptor)
IBA
06/2012
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
12/2011
Therapy/Procedure
27
Therapeutics
01/2022 - 06/2012
8
Drug Therapy (Chemotherapy)
03/2022 - 01/2017
5
Neoadjuvant Therapy
02/2022 - 01/2019
2
Adjuvant Chemotherapy
10/2020 - 01/2017
2
Immunotherapy
12/2019 - 10/2019
2
Precision Medicine
11/2018 - 11/2018
1
Combination Drug Therapy (Combination Chemotherapy)
12/2019